The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study

Purpose High-risk patients with stage II colon cancer (CC) may benefit from adjuvant chemotherapy, but additional prognostic markers are needed for better stratification. We investigated the prognostic value of tumour stroma ratio (TSR) and tumour budding (TB).